Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Link
http://link.springer.com/content/pdf/10.1186/1471-2407-14-777.pdf
Reference33 articles.
1. Kushchayeva Y, Duh Q-Y, Kebebew E, Clark OH: Prognostic indications for Hürthle cell cancer. World J Surg. 2004, 28: 1266-1270. 10.1007/s00268-004-7602-2.
2. Bhattacharyya N: Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003, 129: 207-210. 10.1001/archotol.129.2.207.
3. Hedinger C, Williams ED, Sobin LH: The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer. 1989, 63: 908-911. 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I.
4. Ganly I, Ricarte Filho J, Eng S, Ghossein R, Morris LG, Liang Y, Socci N, Kannan K, Mo Q, Fagin JA, Chan TA: Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013, 98: E962-E972. 10.1210/jc.2012-3539.
5. Kuo EJ, Roman SA, Sosa JA: Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. Surgery. 2013, 154: 1246-1254. 10.1016/j.surg.2013.04.033.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid;Discover Oncology;2023-11-30
2. The Frequency of Differentiated Thyroid Cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy;The Journal of Clinical Endocrinology & Metabolism;2023-09-28
3. Hürthle cell‐predominant thyroid fine needle aspiration cytology: A four risk‐factor model highly accurate in excluding malignancy and predicting neoplasm;Diagnostic Cytopathology;2022-06-08
4. Updated recommendations for the diagnosis and treatment of differentiated thyroid cancer;ONKOLOGIJA;2022
5. Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis;Advances in Therapy;2021-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3